Poolbeg Pharma PLC (POLBF)

Compare

0.1180

0.0000

(0.00%)

As of November 18 at 3:00:00 PM EST. Market Open.

Discover M.T.I Wireless Edge And 2 Other UK Penny Stocks To Watch

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines due to weak trade data from China impacting global economic sentiment. Despite these broader market pressures, investors continue to seek opportunities in lesser-known corners of the market. Penny stocks, often representing smaller or newer companies, remain a relevant area for those looking to explore growth potential at lower price points. In this article, we examine...

Simply Wall St. last month

POLBF
0.00%
THGHY

THGPF
Hookipa Pharma, Poolberg Pharma in Discussions for All-Stock Merger

Hookipa Pharma (HOOK) and Poolbeg Pharma said Thursday that they have entered into non-binding discu

PREMIUM
MT Newswires last month

HOOK

POLBF
0.00%
Gattaca Leads The Charge With 2 Other UK Penny Stocks

The United Kingdom's stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices closing lower amid concerns over China's economic recovery and its impact on global trade. In light of such market conditions, investors may find value in exploring penny stocks, which often represent smaller or newer companies with potential for growth at lower price points. While the term "penny stocks" might seem outdated, these investments can still offer opportunities for those seeking...

Simply Wall St. 2 months ago

AFP.L

GATC.L

POLBF
0.00%
UK Penny Stocks To Watch In November 2024

The UK stock market has recently faced challenges, with the FTSE 100 and FTSE 250 indices slipping due to weak trade data from China, highlighting the interconnectedness of global economies. Despite these broader market pressures, there remains interest in exploring investment opportunities beyond the major players. Penny stocks, while an older term, continue to capture attention for their potential value and growth prospects when backed by strong financials.

Simply Wall St. 3 months ago

GEGYF

GEGYY

SOCLF
Favourable Signals For Poolbeg Pharma: Numerous Insiders Acquired Stock

When a single insider purchases stock, it is typically not a major deal. However, when multiple insiders purchase...

Simply Wall St. 5 months ago

POLBF
0.00%
Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market

LONDON, UK / ACCESSWIRE / July 26, 2024 /Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet ...

ACCESS Newswire 7 months ago

POLBF
0.00%
We Think Poolbeg Pharma (LON:POLB) Can Afford To Drive Business Growth

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Simply Wall St. 7 months ago

POLBF
0.00%
Poolbeg Pharma PLC Announces Notification of Major Holdings

LONDON, UNITED KINGDOM / ACCESSWIRE / July 10, 2024 /TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the ...

ACCESS Newswire 7 months ago

POLBF
0.00%
Poolbeg Pharma PLC Announces Change of Registered Address

Change of Registered Address LONDON, UK / ACCESSWIRE / July 2, 2024 /Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), ('Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting ...

ACCESS Newswire 7 months ago

POLBF
0.00%
Poolbeg Pharma PLC Announces Result of AGM

Results of Annual General Meeting LONDON, UNITED KINGDOM / ACCESSWIRE / June 17, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) ‘Poolbeg' or the ‘Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative ...

ACCESS Newswire 8 months ago

POLBF
0.00%
Poolbeg Pharma PLC Announces Annual Report & AGM Notice

LONDON, UK / ACCESSWIRE / May 9, 2024 /Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high unmet ...

ACCESS Newswire 9 months ago

POLBF
0.00%
Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in USA

Significant POLB 001 Patent Granted in United States Immunomodulator II patent grant further strengthens robust intellectual property portfolio for partnering LONDON, UK / ACCESSWIRE / May 1, 2024 /Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF, 'Poolbeg' ...

ACCESS Newswire 9 months ago

POLBF
0.00%
Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023

Significant pipeline advancements Strategic expansion into cancer immunotherapy-induced CRS unlocking a market opportunity exceeding US$10Bn Key senior management hires LONDON, UK / ACCESSWIRE / April 30, 2024 /Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF); ...

ACCESS Newswire 9 months ago

POLBF
0.00%
Poolbeg Pharma PLC Announces Appointment of Joint Broker

LONDON, UK / ACCESSWIRE / April 30, 2024 /Poolbeg Pharma Plc (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), a biopharmaceutical company focussed on the development and commercialisation of innovative medicines targeting diseases with a high ...

ACCESS Newswire 9 months ago

POLBF
0.00%
Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug Candidate

Exclusive Option Agreement to Acquire Orphan Drug Candidate for Behçet's Disease Novel therapeutic with Fast Track and Orphan Designation LONDON, UK / ACCESSWIRE / April 30, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF), 'Poolbeg' or the 'Company'), ...

ACCESS Newswire 9 months ago

POLBF
0.00%
Poolbeg Pharma PLC Announces TR-1: Notification of Major Holdings

LONDON, UK / ACCESSWIRE / April 29, 2024 /TR-1: Standard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i 1a. Identity of the issuer or ...

ACCESS Newswire 9 months ago

POLBF
0.00%
Poolbeg Pharma PLC Announces POLB 001 US Patent Update

Notice of Allowance for Significant POLB 001 Patent in United StatesNotice of Allowance for Immunomodulator II further strengthens robust intellectual property portfolio LONDON, UK / ACCESSWIRE / March 20, 2024 / Poolbeg Pharma (AIM:POLB)(OTCQB:POLBF) ...

ACCESS Newswire 11 months ago

POLBF
0.00%

Performance Overview

Return	POLBF	FTSE 100
YTD	0.00%	+8.54%
1-Year	+10.28%	+15.47%
3-Year	+18.00%	+22.55%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Poolbeg Pharma PLC (POLBF)

Discover M.T.I Wireless Edge And 2 Other UK Penny Stocks To Watch

Hookipa Pharma, Poolberg Pharma in Discussions for All-Stock Merger

Gattaca Leads The Charge With 2 Other UK Penny Stocks

UK Penny Stocks To Watch In November 2024

Favourable Signals For Poolbeg Pharma: Numerous Insiders Acquired Stock

Poolbeg Pharma PLC Announces Voluntary Delisting from OTCQB Market

We Think Poolbeg Pharma (LON:POLB) Can Afford To Drive Business Growth

Poolbeg Pharma PLC Announces Notification of Major Holdings

Poolbeg Pharma PLC Announces Change of Registered Address

Poolbeg Pharma PLC Announces Result of AGM

Poolbeg Pharma PLC Announces Annual Report & AGM Notice

Poolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in USA

Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023

Poolbeg Pharma PLC Announces Appointment of Joint Broker

Poolbeg Pharma PLC Announces Option Agreement to Acquire Orphan Drug Candidate

Poolbeg Pharma PLC Announces TR-1: Notification of Major Holdings

Poolbeg Pharma PLC Announces POLB 001 US Patent Update

Performance Overview